Literature DB >> 6307709

How increased sodium influx enhances digoxin-induced arrhythmias in guinea-pig atrial muscle.

R H Kennedy, T Akera, T M Brody.   

Abstract

The hypothesis that digitalis-induced arrhythmias occur when Na,K-ATPase inhibition exhausts the sodium pump reserve capacity, producing an accumulation of intracellular Na+, was tested by reducing the reserve capacity in isolated left atrial muscle of guinea pig heart and estimating specific digoxin binding and Na,K-ATPase activity in atrial muscle homogenized at the onset of digoxin-induced arrhythmias. Reductions in reserve capacity were produced by either increasing the stimulation frequency of the atrial muscle or adding a sodium ionophore, monensin, to the media bathing the tissue. As stimulation frequency was increased, both the time required to produce arrhythmias with a given concentration of digoxin and the amount of digoxin bound to sarcolemmal Na,K-ATPase at the onset of arrhythmias were reduced. Similarly, monensin treatment produced reductions in the time to arrhythmia and in digoxin binding and Na,K-ATPase inhibition observed at the onset of arrhythmias. These results support the above proposal suggesting that a decrease in reserve capacity of the sodium pump enhances cardiac sensitivity to digitalis-induced arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307709     DOI: 10.1016/0014-2999(83)90495-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Sodium load and high affinity ouabain binding in rat and guinea-pig cardiac tissue.

Authors:  S Herzig; K Mohr
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

2.  Antiarrhythmic effects of DPI 201-106.

Authors:  G Scholtysik; F M Williams
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

3.  Differential effect of R 56865 on ouabain binding to isolated sarcolemma and intact atrial tissue of guinea-pig.

Authors:  C Heers; E Scheufler; D Wilhelm; D Wermelskirchen; B Wilffert; T Peters
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.